Hikal Q1 Results
- BSE: 524735
- NSE: HIKAL
- ISIN: INE475B01022
- Sector: Biotechnology & Drugs
BSE
172.05
-8.45 (-4.68%)
-8.45 (-4.68%)Volume27.93 K
Updated: Fri 13 Mar, 2026 | 15:28:00
NSE
172.11-8.14 (-4.52%)
-8.14 (-4.52%)Volume2.83 L
Updated: Fri 13 Mar, 2026 | 15:25:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Hikal Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 394.70 | 466.70 | -15.43% | 380.60 | 3.70% |
| Depreciation/ Amortization | 39.40 | 37.70 | 4.51% | 31.80 | 23.90% |
| Operating Income | -14.30 | 85.70 | 0.00% | 26.20 | 0.00% |
| Net Income | -22.40 | 50.20 | 0.00% | 5.10 | 0.00% |
| Other Operating Expenses Total | 105.60 | 133.40 | -20.84% | 99.40 | 6.24% |
| Net Income Before Taxes | -30.40 | 68.30 | 0.00% | 6.90 | 0.00% |
| Total Revenue | 380.40 | 552.40 | -31.14% | 406.80 | -6.49% |
| Selling/ General/ Admin Expenses Total | 62.90 | 63.40 | -0.79% | 57.10 | 10.16% |
| Diluted Normalized EPS | -1.82 | 4.08 | 0.00% | 0.41 | 0.00% |